ArticleMikrochimica acta2026
Gold nanoclusters-mediated enzyme cascade-amplified immunoassay for dual-mode sensing of aflatoxins.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Aflatoxins still pose severe risks to public health due to their high toxicity and carcinogenicity. Herein, we present a novel dual-mode enzyme cascade-amplified immunoassay (ECAIA) for the ultrasensitive and reliable detection of aflatoxins. In this strategy, a nanobody-alkaline phosphatase fusion protein (VHH2-5-AP) was expressed and served as antigen surrogate to compete binding with aflatoxins towards antibody. Bovine serum albumin-gold nanoclusters (BSA-Au NCs) was synthesized and applied as a peroxidase mimic, catalyzing the oxidation of 3,3',5,5'-tetramethylbenzidine (TMB) into its oxidized form (ox TMB), leading to a reduction in fluorescence due to the inner filter effect. VHH2-5-AP could hydrolyzes L-ascorbic acid-2-phosphate (AAP) into ascorbic acid (AA), thus preventing TMB oxidation and restoring BSA-Au NCs' fluorescence. In the presence of aflatoxins, less VHH2-5-AP would be captured, leading to oxTMB accumulation and fluorescence quenching. The proposed ECAIA achieved a limit of detection (LOD) of 0.04 ng/mL for colorimetric detection and 0.24 ng/mL for fluorescence detection with high selectivity for aflatoxins. Moreover, the assay exhibited excellent performance in complex food matrices, achieving recoveries between 84% and 116%, which underscores its considerable potential for practical applications in food safety monitoring.
Indexed as
Identifiers
42176105What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.